Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Tecentriq
Tecentriq
Esmo 2019 preview – immunotherapies grab the rest of the late-breaker focus
EP Vantage
Tue, 09/10/19 - 11:49 pm
ESMO
Keytruda
Tecentriq
Merck
Roche
Roche boosts cancer approvals in Europe, pushing for a bigger slice of the I/O pie
Endpoints
Fri, 09/6/19 - 10:09 am
Roche
Europe
non-squamous cell non-small cell lung cancer
Tecentriq
EMA follows FDA to approve Roche's Tecentriq combo for frontline use in triple negative breast cancer
Endpoints
Thu, 08/29/19 - 12:26 pm
Roche
Tecentriq
FDA
Europe
Celgene
Abraxane
triple negative breast cancer
Mark Your Calendar For These September PDUFA Dates
Yahoo/Benzinga
Wed, 08/28/19 - 12:53 pm
FDA
Roche
Celgene
Tecentriq
Xeris Pharmaceuticals
Gvoke
Ardelyx
tenapanor
Merck
Pifeltro
Delstrigo
Novo Nordisk
semaglutide
JNJ
Genmab
daratumumab
Invokana
Roche says test showed Tecentriq helped vs bladder cancer
Reuters
Mon, 08/5/19 - 11:03 am
Roche
Tecentriq
bladder cancer
Roche closes on EU approval for Tecentriq in breast cancer
Pharmaforum
Mon, 07/1/19 - 11:57 am
Roche
Tecentriq
Europe
triple negative breast cancer
AZ’s Imfinzi on target in small cell lung cancer, sets up Roche rivalry
Pharmaforum
Thu, 06/27/19 - 09:34 am
AstraZeneca
Imfinzi
extensive-stage small cell lung cancer
Roche
Tecentriq
Roche/Exelixis' Cotellic fizzles in pivotal melanoma study
Endpoints
Fri, 06/21/19 - 10:07 am
Roche
Exelixis
Cotellic
Tecentriq
clinical trials
advanced melanoma
Synlogic (SYBX) Enters Cancer Collaboration with Roche
Yahoo/Zacks.com
Fri, 05/24/19 - 10:39 am
Synlogic
Roche
SYNB1891
Tecentriq
solid tumors
Roche throws in the towel on Tecentriq bladder, myeloma trials
Fierce Pharma
Fri, 04/19/19 - 06:16 pm
Roche
Tecentriq
bladder cancer
Multiple Myeloma
clinical trials
Roche’s Tecentriq gains new US lung cancer indication
Pharmaforum
Tue, 03/19/19 - 11:41 am
Roche
Genentech
Tecentriq
FDA
extensive-stage small cell lung cancer
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings
Yahoo/Benzinga
Sat, 03/16/19 - 12:25 pm
Roche
SAGE Therapeutics
Ligand Pharmaceuticals
brexanolone
Tecentriq
Jazz Pharmaceuticals
JZP-110
Sanofi
Lexicon Pharmaceuticals
Zynquista
PhaseBio
AstraZeneca
Amarin
Leap Therapeutics
Strongbridge
UK gets early access to Roche’s breast cancer immunotherapy
Pharmaforum
Sat, 03/16/19 - 12:18 pm
Roche
Tecentriq
Celgene
Abraxane
UK
triple-negative breast cancer
Roche's Tecentriq gains expanded approval in US for PD-L1-positive, triple-negative breast cancer
First Word Pharma
Fri, 03/8/19 - 02:27 pm
Roche
Genentech
FDA
Tecentriq
triple negative breast cancer
Roche gets European approval for Tecentriq combo vs. lung cancer
Reuters
Fri, 03/8/19 - 10:12 am
Roche
Europe
Tecentriq
Avastin
lung cancer
metastatic non-squamous non-small cell lung cancer
Basilea Enters Collaboration With Roche to Study BAL087 in Combination With Tecentriq in Urothelial Cancer
CP WIre
Thu, 01/24/19 - 11:43 am
Arqule
Basilea
Roche
BAL087
urothelial cancer
Tecentriq
Basilea Enters Collaboration With Roche to Study BAL087 in Combination With Tecentriq in Urothelial Cancer
Thu, 01/24/19 - 10:38 am
Arqule
Basilea
Roche
BAL087
urothelial cancer
Tecentriq
Down but Not Out: 10 Biggest Drug Trials That Saw Challenges in 2018
BioSpace
Fri, 12/21/18 - 12:10 pm
clinical trials
Takeda
Zinfandel Pharmaceuticals
pioglitazone
Alzheimer's disease
Boehringer Ingelheim
BI 409306
Merck
verubecestat
Celgene
MS
ozanimod
Incyte
ID01
melanoma
vTv Therapeutics
azeliragon
Roche
Tecentriq
Exelixis
colorectal cancer
JNJ
atabacestat
Sareptat Therapeutics
DMD
Exondys 51
Alkermes
ALKS-5461
clinical depression
Genentech Scores FDA Approval for Tecentriq and Avastin Combo in NSCLC
BioSpace
Fri, 12/7/18 - 11:59 am
Genentech
FDA
Tecentriq
Avastin
non-squamous cell non-small cell lung cancer
Tecentriq could be first front-line SCLC therapy approved in two decades
BioCentury
Wed, 12/5/18 - 07:46 pm
FDA
Tecentriq
Genentech
extensive-stage small cell lung cancer
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »